Markets

Market Nav

NINE MONTHS RESULTS

Aarti Pharmalabs Ltd.
( in Crs.)

ParticularsDec 24Dec 23Dec 22
Net Sales/Income from operations1241.731087.311914.63
Total Income From Operations1241.731087.311914.63
    
EXPENDITURE   
Consumption of Raw Materials630.27581.631184.21
Purchase of Traded Goods24.0914.0119.01
Increase/Decrease in Stocks-35.19-30.72-155.79
Employees Cost111.5095.66149.55
Depreciation58.2348.6968.48
Other Expenses227.64187.92327.14
Total Expenses1016.54897.191592.60
    
P/L Before Other Inc. , Int., Excpt. Items & Tax225.19190.12322.03
Other Income17.005.322.52
P/L Before Interest, Excpt. Items & Tax242.18195.45324.55
Interest19.3412.2124.26
P/L Before Exceptional Items & Tax222.84183.24300.29
P/L Before Tax222.84183.24300.29
Tax54.3445.6175.38
P/L After Tax from Ordinary Activities168.50137.63224.91
Net Profit/Loss For the Period168.50137.63224.91
    
Equity Share Capital45.3145.3145.31
EPS Before Extra Ordinary *   
Basic EPS (Rs.)18.5915.1924.82
Diluted EPS (Rs.)18.5815.1924.82
EPS After Extra Ordinary *   
Basic EPS (Rs.) 18.5915.1924.82
Diluted EPS (Rs.) 18.5815.190.00
    
PBITOE Margin (%)18.1317.4816.81
PBTE Margin (%)17.9416.8515.68
PBT Margin (%)17.9416.8515.68
PAT Margin (%)13.5712.6511.74
ParticularsDec 24
Net Sales/Income from operations1241.73
Total Income From Operations1241.73
  
EXPENDITURE 
Consumption of Raw Materials630.27
Purchase of Traded Goods24.09
Increase/Decrease in Stocks-35.19
Employees Cost111.50
Depreciation58.23
Other Expenses227.64
Total Expenses1016.54
P/L Before Other Inc. , Int., Excpt. Items & Tax225.19
Other Income17.00
P/L Before Interest, Excpt. Items & Tax242.18
Interest19.34
P/L Before Exceptional Items & Tax222.84
P/L Before Tax222.84
Tax54.34
P/L After Tax from Ordinary Activities168.50
Net Profit/Loss For the Period168.50
Equity Share Capital45.31
EPS Before Extra Ordinary * 
Basic EPS (Rs.)18.59
Diluted EPS (Rs.)18.58
EPS After Extra Ordinary * 
Basic EPS (Rs.) 18.59
Diluted EPS (Rs.) 18.58
PBITOE Margin (%)18.13
PBTE Margin (%)17.94
PBT Margin (%)17.94
PAT Margin (%)13.57